NEW BIOLOGICS TO PREVENT SWINE TGE AND PSEUDORABIES

AMTRON, INC. WILL UNDERTAKE PRODUCTION AND TESTING LEADING TO U.S. DEPARTMENT OF AGRICULTURE (USDA) APPROVAL OF TWO IM-MUNITY INDUCERS(OFFICIAL NAME DISIGNATED BY USDA) TO PREVENTTHE OCCURENCE OF TRANSMISSIBLE GASTROENTERITIS (TGE) AND PSEUDORABIES VIRUS (PRV) IN NEWBORN PIGS. THE DEVELOPMENT OF IMMUNITY INDUCERS STEMS FROM ADVANCED RESEARCH IN IMMUNO-MODULATORS IN PHASE I, WHICH HAS ENABLED THE COMPANY TO DEM ONSTRATE THE FEASIBILITY OF HARVESTING LARGE QUANTITIES OF IMMUNOMODULATORS SPECIFIC TO THE DISEASES IN QUESTION (AND NUMEROUS OTHERS) WITHOUT HARM TO THE SOURCE ANIMALS. THE PROCESS OF PRODUCING TGE AND PRV IMMUNITY INDUCERS WILL BE FURTHER DEFINED AND CLINICALLY TESTED IN THIS PROJECT IN CONJUNCTION WITH OUTSIDE CONTRACTORS, AND SUFFICIENT SERIALSOF EACH PRODUCT WILL BE PRODUCED TO MEET USDA GUIDELINES FOR COMMERCIAL APPLICATION OF THESE BIOLOGIC PRODUCTS. THIS PROJECT WILL REQUIRE A MINIMUM OF 15 MONTHS TO COMPLETE AND SHOULD RESULT IN USDA APPROVAL FOR COMMERCIAL USE OF THESE PRODUCTS, BOTH OF WHICH WILL SIGNIFICANTLY IMPROVE SWINE PRODUCTION BECAUSE OF THE PRESENT ABSENCE OF EFFICACIOUS TGE AND PRV VACCINES THAT CAN INDUCE IMMUNITY DURING THE FIRST FEW DAYS OF LIFE IN PIGLETS. THE PRODUCTION OBJECTIVEOF THIS PROJECT WILL BE HALF A MILLION DOSES OF IMMUNITY IN-DUCERS FOR BOTH DISEASES.